| 105.06 |  +1.06 / +1.02% |
Data as of 4:02pm ET | Day’s Change |
| 105.06 |  0.00 / 0.00% |
Volume: 7.8K |
| Bard Begins Lutonix BTK Trial - Analyst Blog 1:53pm / Zacks.com | CR Bard Reiterated at Neutral - Analyst Blog Jun 05 / Zacks.com |
| Previous close | 104.00 |
| Today’s open | 104.12 |
| Day’s range | 103.09 - 105.06 |
| Volume | 642,560 |
| Average volume (3 months) | 645,684 |
| Market cap | $8.4B |
| Dividend yield | 0.76% |
| Earnings growth (last year) | +66.94% |
| Earnings growth (this year) | -4.76% |
| Earnings growth (next 5 years) | +10.00% |
| Revenue growth (last year) | +2.13% |
| P/E ratio | 18.6 |
| Price/Sales | 2.75 |
| Price/Book | 4.41 |
| Today’s change | Today’s % change | |
|---|---|---|
| CFNCareFusion Corp | +0.08 | +0.21% |
| EWEdwards Lifesciences... | -0.07 | -0.11% |
| MRMindray Medical Inte... | +0.46 | +1.14% |
| BSXBoston Scientific Co... | +0.18 | +2.00% |
| Next reporting date | July 23, 2013 |
| EPS forecast (this quarter) | $1.38 |
| Annual revenue (last year) | $3.0B |
| Annual profit (last year) | $520.1M |
| Net profit margin | 17.58% |
Sector Health Technology |
Industry Medical Specialties |
Chairman & Chief Executive Officer Tim M. Ring, |
President, Chief Operating Officer & Director John H. Weiland, MBA |
Corporate headquarters Murray Hill, New Jersey |
.
